サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1362892

整形外科用バイオマテリアルの市場規模、シェア、動向分析レポート：タイプ別、用途別、地域別、セグメント別予測、2023年～2030年

Orthopedic Biomaterials Market Size, Share & Trends Analysis Report By Type (Ceramics & Bioactive Glasses, Polymers, Calcium Phosphate Cements), By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
整形外科用バイオマテリアルの市場規模、シェア、動向分析レポート：タイプ別、用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月05日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

整形外科用バイオマテリアル市場の成長と動向：

整形外科用バイオマテリアルの世界市場規模は、2023年から2030年にかけてCAGR 7.8%を記録し、2030年には359億米ドルに達すると予測されます。

退行性関節疾患と筋骨格系障害の罹患率の増加が市場を牽引する主な要因です。さらに、骨密度の低下や骨関連疾患の進行により整形外科的疾患にかかりやすい老年人口の増加が、予測期間中の製品需要を押し上げると予想されます。

セラミック＆生体活性ガラスは、その高い圧縮強度によるこれらの材料への需要の高まりから、2022年の材料タイプ別セグメントで優位を占めました。また、セラミックス＆生体活性ガラス系バイオマテリアルは、骨の表面材料と一体化する親和性が高いため、同種のバイオマテリアルよりも好まれています。しかし、ポリマー生体材料セグメントは、脊椎、股関節、膝関節の再建・固定術にこれらの材料が多く使用されていることから、2023年から2030年にかけて最も速いCAGRを記録すると予想されています。

整形外科用インプラントは2022年に用途別セグメントをリードし、予測期間中も支配的な地位を維持すると予測されています。外傷症例の増加は、このセグメントの成長を促進する主な要因の1つです。整形生物学セグメントは、2023年から2030年にかけて最も速いCAGR 7.7％になると予測されています。脊椎やその他の再建手術の治療のために、さまざまな整形生物工学における生体材料の採用が増加していることが、このセグメントの成長を促進すると予測されています。

北米は、関節置換術／再建術、骨修復術、その他の整形外科手術の需要が高く、対象人口が多いことから、2022年の市場をリードしました。さらに、生体吸収性製品に関する認知度の向上と相まって、高度な治療オプションに対する需要の高まりが、今後の製品需要を牽引すると予想されます。

整形外科用バイオマテリアル市場のレポートハイライト

  • 北米は患者数が多く、生体吸収性バイオマテリアルの使用に関する認知度が高いため、2022年に最大の売上シェアを占めました。
  • セラミックと生体活性ガラスセグメントは、損傷した組織の修復、固定手術、関節置換手術のためにこれらの生体材料の使用量が増加しているため、2022年の市場をリードしました。
  • 整形外科用インプラントは、世界の外傷症例数の増加により、2022年に支配的なアプリケーションセグメントとなっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 整形外科用バイオマテリアル市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 整形外科用バイオマテリアル市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 整形外科用バイオマテリアル：タイプの推定・動向分析

  • 整形外科用バイオマテリアル市場：重要なポイント
  • 整形外科用バイオマテリアル市場：動向と市場シェア分析、2022年および2030年
  • セラミックスと生体活性ガラス
  • ポリマーバイオマテリアル
  • リン酸カルシウムセメント
  • 金属バイオマテリアル
  • 複合材料

第5章 整形外科用バイオマテリアル：用途の推定・動向分析

  • 整形外科用バイオマテリアル市場：重要なポイント
  • 整形外科用バイオマテリアル市場：動向と市場シェア分析、2022年および2030年
  • 整形外科用インプラント
  • 関節置換術
  • オーソバイオロジクス
  • 関節内補充療法
  • 生体吸収性組織の固定

第6章 整形外科用バイオマテリアル市場：地域の推定・動向分析

  • 地域別の見通し
  • 地域別の整形外科用バイオマテリアル市場：主要なマーケットプレース要点
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • DSM Biomedical
    • Evonik Industries Ag
    • Stryker
    • Depuy Synthes Inc.
    • Zimmer Biomet
    • Invibio Ltd
    • Schiller
    • Cardinal Health
図表

List of Tables

  • TABLE 1 List of Abbreviations
  • TABLE 2 North America orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 3 North America orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 4 North America orthopedic biomaterials market, by region, 2018 - 2030 (USD Million)
  • TABLE 5 U.S. orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 6 U.S. orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 7 Canada orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 8 Canada orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 9 Europe orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 10 Europe orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 11 Europe orthopedic biomaterials market, by region, 2018 - 2030 (USD Million)
  • TABLE 12 Germany orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 13 Germany orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 14 UK orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 15 UK orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 16 France orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 17 France orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 18 Italy orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 19 Italy orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 20 Spain orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 21 Spain orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 22 Sweden orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 23 Sweden orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 24 Norway orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 25 Norway orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 26 Denmark orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 27 Denmark orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 28 Asia Pacific orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 29 Asia Pacific orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 30 Asia Pacific orthopedic biomaterials market, by region, 2018 - 2030 (USD Million)
  • TABLE 31 China orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 32 China orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 33 Japan orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 34 Japan orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 35 India orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 36 India orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 37 Australia orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 38 Australia orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 39 Thailand orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 40 Thailand orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 41 South Korea orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 42 South Korea orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 43 Latin America orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 44 Latin America orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 45 Latin America orthopedic biomaterials market, by region, 2018 - 2030 (USD Million)
  • TABLE 46 Brazil orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 47 Brazil orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 48 Mexico orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 49 Mexico orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 50 Argentina orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 51 Argentina orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 52 Middle East and Africa orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 53 Middle East and Africa orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 54 Middle East and Africa orthopedic biomaterials market, by region, 2018 - 2030 (USD Million)
  • TABLE 55 South Africa orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 56 South Africa orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 57 Saudi Arabia orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 58 Saudi Arabia orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 59 UAE orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 60 UAE orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)
  • TABLE 61 Kuwait orthopedic biomaterials market, by type, 2018 - 2030 (USD Million)
  • TABLE 62 Kuwait orthopedic biomaterials market, by application, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Data triangulation techniques
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value-chain-based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Orthopedic Biomaterials: Market outlook
  • FIG. 9 Orthopedic Biomaterials: Competitive insights
  • FIG. 10 Parent market outlook
  • FIG. 11 Related/ancillary market outlook
  • FIG. 12 Penetration and growth prospect mapping
  • FIG. 13 Industry value chain analysis
  • FIG. 14 Orthopedic biomaterials market driver impact
  • FIG. 15 Orthopedic biomaterials market restraint impact
  • FIG. 16 Orthopedic biomaterials market strategic initiatives analysis
  • FIG. 17 Orthopedic biomaterials market: Type movement analysis
  • FIG. 18 Orthopedic biomaterials market: Type outlook and key takeaways
  • FIG. 19 Ceramics and bioactive glasses market estimates and forecasts, 2018 - 2030
  • FIG. 20 Polymers biomaterials market estimates and forecasts, 2018 - 2030
  • FIG. 21 Calcium phosphate cements market estimates and forecasts, 2018 - 2030
  • FIG. 22 Metal biomaterials market estimates and forecasts, 2018 - 2030
  • FIG. 23 Composites market estimates and forecasts, 2018 - 2030
  • FIG. 24 Orthopedic biomaterials market: Application movement analysis
  • FIG. 25 Orthopedic biomaterials market: Application outlook and key takeaways
  • FIG. 26 Orthopedic implants market estimates and forecasts, 2018 - 2030
  • FIG. 27 Joint replacement market estimates and forecasts, 2018 - 2030
  • FIG. 28 Orthobiologics market estimates and forecasts, 2018 - 2030
  • FIG. 29 Viscosupplementation market estimates and forecasts, 2018 - 2030
  • FIG. 30 Bio-resorbable tissue fixation market estimates and forecasts, 2018 - 2030
  • FIG. 31 Global Orthopedic biomaterials market: Regional movement analysis
  • FIG. 32 Global Orthopedic biomaterials market: Regional outlook and key takeaways
  • FIG. 33 North America market estimates and forecasts, 2018 - 2030
  • FIG. 34 U.S. market estimates and forecasts, 2018 - 2030
  • FIG. 35 Canada market estimates and forecasts, 2018 - 2030
  • FIG. 36 Europe. market estimates and forecasts, 2018 - 2030
  • FIG. 37 UK market estimates and forecasts, 2018 - 2030
  • FIG. 38 Germany market estimates and forecasts, 2018 - 2030
  • FIG. 39 France market estimates and forecasts, 2018 - 2030
  • FIG. 40 Italy market estimates and forecasts, 2018 - 2030
  • FIG. 41 Spain market estimates and forecasts, 2018 - 2030
  • FIG. 42 Sweden market estimates and forecasts, 2018 - 2030
  • FIG. 43 Norway market estimates and forecasts, 2018 - 2030
  • FIG. 44 Denmark market estimates and forecasts, 2018 - 2030
  • FIG. 45 Asia Pacific market estimates and forecasts, 2018 - 2030
  • FIG. 46 Japan market estimates and forecasts, 2018 - 2030
  • FIG. 47 China market estimates and forecasts, 2018 - 2030
  • FIG. 48 India market estimates and forecasts, 2018 - 2030
  • FIG. 49 Australia market estimates and forecasts, 2018 - 2030
  • FIG. 50 Thailand market estimates and forecasts, 2018 - 2030
  • FIG. 51 South Korea market estimates and forecasts, 2018 - 2030
  • FIG. 52 Latin America market estimates and forecasts, 2018 - 2030
  • FIG. 53 Brazil market estimates and forecasts, 2018 - 2030
  • FIG. 54 Mexico market estimates and forecasts, 2018 - 2030
  • FIG. 55 Argentina market estimates and forecasts, 2018 - 2030
  • FIG. 56 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • FIG. 57 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • FIG. 58 South Africa market estimates and forecasts, 2018 - 2030
  • FIG. 59 UAE market estimates and forecasts, 2018 - 2030
  • FIG. 60 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-3-68038-152-8

Orthopedic Biomaterials Market Growth & Trends:

The global orthopedic biomaterials market size is expected to reach USD 35.90 billion by 2030, registering a CAGR of 7.8% from 2023 to 2030. Increasing incidence of degenerative joint disease and musculoskeletal disorders is the key factor driving the market. In addition, increasing geriatric population susceptible to orthopedic conditions arising due to low bone density and advancing bone related disorders is expected to boost the product demand over the forecast period.

Ceramics & bioactive glass was the dominant material type segment in 2022 on account of growing demand for these materials due to their high compression strength. In addition, ceramics & bioactive glass biomaterials are preferred over their counterparts as they have a high affinity to integrate with the surface material of the bone. However, polymer biomaterial segment is expected to witness the fastest CAGR from 2023 to 2030 owing to high usage of these materials for the reconstruction and fixation procedures of the spine, hip, and knee.

Orthopedic implants led the application segment in 2022 and are expected to remain dominant over the forecast period. Increasing number of trauma cases is one of the major factors driving the growth of this segment. Orthobiologics segment is anticipated to witness the fastest CAGR of 7.7% from 2023 to 2030. Increasing adoption of biomaterials in various orthobiologics for the treatment of spinal and other reconstructive surgeries is anticipated to drive the growth of this segment.

Led by U.S. North America led the market in 2022 owing to high demand for joint replacement/reconstruction, bone repair, and, other orthopedic procedures due to the presence of target population. Moreover, rise in the demand for advanced treatment options coupled with increasing awareness about bio-resorbable products is expected to drive the product demand in future.

Orthopedic Biomaterials Market Report Highlights:

  • North America accounted for the largest revenue share in 2022 owing to large patient pool and high awareness regarding the use of bio-resorbable biomaterials
  • Ceramics and bioactive glass segment led the market in 2022 owing to increased usage of these biomaterials for the restoration of damaged tissue and fixation surgeries and joint replacement surgeries
  • Orthopedic implants was the dominant application segment in 2022 due to an increased number of trauma cases worldwide
  • Some of the key companies in orthopedic biomaterials market are DSM Biomedical; Evonik Industries AG; Stryker Corp.; DePuy Synthes, Inc.; Zimmer Biomet; Invibio Ltd.; Globus Medical; Exactech, Inc.; Matexcel; AdvanSource Biomaterials Corp.; CAM Bioceramics B.V.; and Heraeus Holding

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Orthopedic Biomaterials Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Growing incidences of musculoskeletal ailments and chronic skeletal conditions
      • 3.3.1.2. Growing geriatric population across the globe
      • 3.3.1.3. Increase in the number of patients requiring a knee replacement, reconstruction, and other joint-related orthopedic procedures.
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Manufacturers are forced to lower prices on premium products
      • 3.3.2.2. Orthopedic biomaterial products face reimbursement challenges
  • 3.4. Orthopedic Biomaterials Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Orthopedic Biomaterials: Type Estimates & Trend Analysis

  • 4.1. Orthopedic Biomaterials Market: Key Takeaways
  • 4.2. Orthopedic Biomaterials Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Ceramics and bioactive glasses
    • 4.3.1. Ceramics and bioactive glasses market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Polymers Biomaterials
    • 4.4.1. Polymers biomaterials market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Calcium Phosphate Cements
    • 4.5.1. Calcium phosphate cements market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Metal Biomaterials
    • 4.6.1. Metal biomaterials market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Composites
    • 4.7.1. Composites market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Orthopedic Biomaterials: Application Estimates & Trend Analysis

  • 5.1. Orthopedic Biomaterials Market: Key Takeaways
  • 5.2. Orthopedic Biomaterials Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Orthopedic implants
    • 5.3.1. Orthopedic implants market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Joint Replacement
    • 5.4.1. Joint replacement estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Orthobiologics
    • 5.5.1. Orthobiologics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Viscosupplementation
    • 5.6.1. Viscosupplementation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Bio-Resorbable Tissue Fixation
    • 5.7.1. Bio-resorbable tissue fixation market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Orthopedic Biomaterials Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Orthopedic Biomaterials Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. DSM Biomedical
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Product Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. Evonik Industries Ag
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Product Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Stryker
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Product Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. Depuy Synthes Inc.
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Product Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. Zimmer Biomet
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Product Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. Invibio Ltd
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Product Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. Schiller
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Product Benchmarking
      • 7.2.7.4. Strategic Initiatives
    • 7.2.8. Cardinal Health
      • 7.2.8.1. Company Overview
      • 7.2.8.2. Financial Performance
      • 7.2.8.3. Product Benchmarking
      • 7.2.8.4. Strategic Initiatives